ArticleEmerging microbes & infections2026

Preclinical characterization of HEC116094, an oral inhibitor of the influenza A virus polymerase PB2 subunit.

Longyu Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.